In summary, the results show that the quality markers of MCG can reduce the survival rate of breast cancer cells better by acting on PIK3CG, PIK3CA, mTOR, AR genes and co-regulating the effector genes MDM2, P53, PSA, S6K (Figure 6F). This evidence concerns the gene KLK3 and breast cancer.